default author photo

Elizabeth R. Brown

University of Washington - Vaccine and Infectious Disease Division

SCHOLARLY PAPERS

5

DOWNLOADS

391

TOTAL CITATIONS

6

Scholarly Papers (5)

1.

Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical Trial

Number of pages: 43 Posted: 09 Dec 2020
University of Washington, University of Washington - Vaccine and Infectious Disease Division, Division of Allergy and Infectious Diseases, University of Washington, University of Washington - Division of Allergy and Infectious Diseases, School of Public Health and Tropical Medicine, Tulane University, School of Medicine, Tulane University, John H. Stroger, Jr., Hospital of Cook County, John H. Stroger, Jr., Hospital of Cook County, Boston University School of Medicine, Walter Reed Army Institute of Research - Clinical Trials Center, Department of Global Health, University of Washington, Department of Global Health, University of Washington, Department of Global Health, University of Washington, Vaccine and Infectious Disease Division, University of Washington, New York University (NYU) - Grossman School of Medicine, Division of Cardiology, University of Washington, Division of Cardiology, University of Washington, Mayo Clinic, Mayo Clinic, Department of Global Health, University of Washington, Department of Laboratory Medicine and Pathology, University of Washington, University of Washington - Department of Laboratory Medicine and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington, University of Washington - Department of Medicine, Fred Hutchinson Cancer Research Center - Clinical Research Division, University of Washington - Department of Global Health, University of Washington - Division of Allergy and Infectious Diseases, Division of Allergy and Infectious Diseases, University of Washington, University of Washington - Department of Global Health and Independent
Downloads 131 (554,631)
Citation 2

Abstract:

Loading...

coronavirus, COVID-19, SARS-CoV-2, hydroxychloroquine, azithromycin, early treatment, remote enrollment, randomized controlled trial

2.

NVX-CoV2373 Efficacy in Preventing SARS-CoV-2 Infection in Adolescents

Number of pages: 26 Posted: 22 Dec 2023
University of Maryland, College Park, University of Washington - Vaccine and Infectious Disease Division, - Center for Vaccine Development and Global Health, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Government of the United States of America - Division of Bacterial Diseases, - Institute for Genome Sciences, University of Maryland School of Medicine, Institute for Genome Studies, Research Your Health, Meridian Clinical Research, M3-Emerging Medical Research, - Center for Vaccine Development and Global Health, Biomedical Advanced Research and Development Authority (BARDA), Biomedical Advanced Research and Development Authority (BARDA), Biomedical Advanced Research and Development Authority (BARDA), Walter Reed Army Institute of Research - U.S. Military HIV Research Program, - Center for Vaccine Development and Global Health, - Center for Vaccine Development and Global Health, Government of the United States of America - National Institutes of Health (NIH), - Department of Pediatrics, Independent, Ponce Health Sciences University, Independent, University of California, Davis, Independent, Independent, University of North Carolina (UNC) at Chapel Hill - School of Medicine, Independent, Independent, DM Clinical Research, Independent, Meridian Clinical Research, Velocity Clinical Research, Independent, Atrium Health and Universidad Linda Vista
Downloads 113 (626,371)

Abstract:

Loading...

Protein vaccine, immunization, COVID-19, SARS-CoV-2, adolescent, vaccine efficacy, infection, delta, asymptomatic infection, transmission

3.

Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant

Number of pages: 57 Posted: 08 Apr 2022
University of Maryland, Baltimore (UMB), Baylor College of Medicine, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, affiliation not provided to SSRN, affiliation not provided to SSRN, - School of Medicine, Duke University - Duke Human Vaccine Institute, Kaiser Permanente Washington Health Research Institute, University of Rochester - Division of Infectious Diseases, Baylor College of Medicine, Emory University School of Medicine and Children’s Healthcare of Atlanta - Department of Pediatrics, University of Pittsburgh - School of Medicine, University of Washington, University of Texas Medical Branch-Galveston - The Sealy Institute for Vaccine Sciences, New York University (NYU) - Grossman School of Medicine, University of Cincinnati - College of Medicine, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, New York University (NYU) - New York University Long Island School of Medicine, New York University (NYU) - Grossman School of Medicine, affiliation not provided to SSRN, University of Pittsburgh - School of Medicine, Emory University - School of Medicine, affiliation not provided to SSRN, Seattle Children’s Research Institute, affiliation not provided to SSRN, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), affiliation not provided to SSRN, University of Washington - Vaccine and Infectious Disease Division, - Center for Vaccine Development and Global Health, affiliation not provided to SSRN, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Emory University - Center for Childhood Infections and Vaccines, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Duke University - Duke Human Vaccine Institute and affiliation not provided to SSRN
Downloads 76 (830,555)
Citation 4

Abstract:

Loading...

COVID-19, SARS-CoV-2, Booster, Vaccine, Omicron variant, B.1.1.529, Neutralizing antibody, mRNA vaccine, recombinant adenovirus vaccine

4.

High incidence, Re-infection, and Clinical Morbidity of Sexually Transmitted Infections Despite Interval Testing and Treatment Among Kenyan Adolescent Girls and Young Women: Evidence from a 4·5-Year Cohort Study

Number of pages: 27 Posted: 22 Dec 2025
Maricianah Onono, Kidist Zewdie, Elizabeth R. Brown and See PDF
Kenya Medical Research Institute (KEMRI), Fred Hutchinson Cancer Research Center, University of Washington - Vaccine and Infectious Disease Division and Please see PDF for full list of authors & affiliations
Downloads 39 (1,196,171)

Abstract:

Loading...

Adolescent girls and young women (AGYW), Sexually transmitted infections (STIs), Asymptomatic infections, Reinfection, Syndromic management, Etiologic STI screening, Partner notification, Kenya

5.

High agreement of Seegene AnyplexTM HPV 28 and AllplexTM HPV 28 for High-Risk Vaccine-Type HPV Detection in the KEN SHE Study

Number of pages: 8 Posted: 09 Mar 2026
Harvard University - Massachusetts General Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Kenya Medical Research Institute (KEMRI), University of California, San Francisco (UCSF) - Department of Obstetrics, Gynecology & Reproductive Sciences, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Washington - Vaccine and Infectious Disease Division, University of Washington - Department of Global Health and Harvard University - Massachusetts General Hospital
Downloads 32 (1,290,922)

Abstract:

Loading...

Allplex HPV28, Anyplex HPV28, PCR, HPV, HPV vaccine, persistent HPV